Your search for ‘Spruson & Ferguson’ returned 1,282 results

Article discusses recent decision where Apple lost the case where it opposed extension of a trademark.

This change opens up technology imports to negotiation without mandatory restrictions which protected Chinese entities.

The Cooperative Research Centre for Mining (CRCMining) has developed a baseball cap headware technology to measure and manage drowsiness in real time, in order to overcome a significant driver fatigue problem in the coal mining industry.

The Cooperative Research Centre for Mining (CRCMining) has developed a baseball cap headware technology to measure and manage drowsiness in real time, in order to overcome a significant driver fatigue problem in the coal mining industry

In 2015, the High Court of Australia ruled against the patentability of isolated human genes.

This Productivity Commission report evoked a range of conflicting views as to the best policy to incentivise innovation.

Google, Inc (Google) has successfully opposed an application for registration of the GOOGLEBAY mark in the name of Dmitri Rystk (Rystk), covering consumer market information services in Class 35.

70 per cent of local IP protection filings in Australia come from SMEs.

IP Australia, in line with reviews in other jurisdictions, is seeking to address concerns around certainty of patent rights arising from the filing of divisional applications, particularly where divisional applications are filed with identical or substantially identical claims to those originally filed in the parent application(s).

IP Australia, in line with reviews in other jurisdictions, is seeking to address concerns around certainty of patent rights arising from the filing of divisional applications, particularly where divisional applications are filed with identical or substantially identical claims to those originally filed in the parent application(s).

If directions in the prior art lead to the carrying out of the invention, there are grounds to invalidate the patent.

Alphapharm and other generic manufacturers may considerable damages for the infringement of the Escitalopram Patent.

The new Act can be considered an opportunity and a threat in equal measure.

The PROCAT trade mark was found sufficiently different to the Cat marks, so was unlikely to cause deception or confusion.

ENBREL is Pfizer's autoimmune disorder therapy, used to treat various chronic diseases, including rheumatoid arthritis.

One of the principal criticisms of the patent system is that it is often prohibitively expensive for "the little guy". Statistics reflect the fact that the large corporate tends to make better use of the patent system than does the individual inventor, who may struggle to attract funding. This article outlines a new initiative of the Australian Federal Government which may go some way to redressing this imbalance.